BALYASNY ASSET MANAGEMENT LLC 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:11 am Sale |
2021-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
BALYASNY ASSET MANAGEMENT LLC | 0 0.000% |
-4,408,952 (Position Closed) |
Filing |
| 2021-12-03 06:09 am Purchase |
2021-11-23 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
BALYASNY ASSET MANAGEMENT LLC | 4,408,952 5.670% |
4,408,952 (New Position) |
Filing |